Filing Details
- Accession Number:
- 0001627223-17-000052
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2017-09-05 09:12:54
- Reporting Period:
- 2017-08-31
- Accepted Time:
- 2017-09-05 08:12:54
- Original Submission Date:
- 2017-09-05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1627223 | Chemours Co | CC | Chemicals & Allied Products (2800) | 464845564 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645179 | C David Shelton | C/O The Chemours Company 1007 Market Street Wilmington DE 19899 | Svp, Gc & Corp. Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-31 | 13,337 | $12.96 | 54,766 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-31 | 13,337 | $48.48 | 41,429 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-31 | 13,337 | $0.00 | 13,337 | $12.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-02-06 | 2019-02-06 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 492 | Indirect | By Spouse |
Footnotes
- The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2017.
- Includes directly owned shares, unvested restricted stock units and dividend equivalent units.
- Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $48.18 to $48.60.
Billionaire Hedge Funds
